Early use of tocilizumab and lead-in dose to mitigate flotetuzumab associated infusion-related reaction/cytokine release reaction in patients with relapsed or refractory acute myeloid leukemia. Issue 3 (2020) - Jacobs, Kenneth; Bakkacha, Ouiam; Patel, Priyanka
No abstract available